Skip to contentB
BioCorRx Inc.
B
BICXBioCorRx Inc. Q2 2016 · 10-Q
Revenue$187.91K$187.91K−59.0% vs Q2 2015 Net Income-$1.07M-$1.07MN/M vs Q2 2015 EPS Diluted-$0.01-$0.01N/M vs Q2 2015 Operating Income-$412,292N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BioCorRx Inc. · CIK 1443863 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$734,728— Margins · derivedOperating margin-219.4%+634.2 pt vs Q2 2015
Net margin-571.4%+252.3 pt vs Q2 2015
ended Jun 30, 2016 · filed Aug 17, 2016 · 48 d after period end